133 results on '"Biasiolo, Alessandra"'
Search Results
2. Le complexe antigène de carcinome à cellules squameuses-IgM (SCCA-IgM) est associé à la pneumopathie interstitielle diffuse dans la sclérodermie systémique
3. Inhibition of Protease-Activated Receptor-2 Activation in Parkinson's Disease Using 1-Piperidin Propionic Acid.
4. Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis
5. PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting
6. The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation.
7. SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma.
8. Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma.
9. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study
10. 1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2.
11. Serpinb3 is overexpressed in the liver in presence of iron overload
12. SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness.
13. SAT-219 Discovering 1-piperidine propionic acid inhibiting effect on protease activated receptor 2 and serpinb3 as a new therapeutic strategy for metabolic dysfunction-associated steatohepatitis
14. The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker
15. SERPINB3 modulates TGF-β expression in chronic liver disease
16. SerpinB3 administration protects liver against ischemia-reperfusion injury.
17. Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo.
18. Detection of high levels of Survivin–immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis
19. SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease.
20. Oncostatin M is overexpressed in NASH‐related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis.
21. WED-449 - Inhibition of CCAT/enhancer-binding protein beta-serpinB3 axis by 1-piperidin propionic acid: a new targeted therapy for non-alcoholic steatohepatitis
22. Antiphospholipid antibody ELISAs: Survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-β 2-Glycoprotein I activity
23. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism
24. Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity
25. THE ROLE OF SCCA-IGM DETERMINATION IN BARRETTʼS ESOPHAGUS AND ESOPHAGEAL CANCER: O09.07
26. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis
27. The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma.
28. Use of a New Silica Clotting Time for Diagnosing Lupus Anticoagulant in Patients Who Meet the Clinical Criteria for Antiphospholipid Syndrome
29. Mechanical Prosthetic Heart Valve Thrombosis Despite Optimal Anticoagulation in a Patient with Congenital Thrombophilia (Factor V Leiden)
30. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis
31. Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma.
32. Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis.
33. Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity.
34. SERPINB3 Delays Glomerulonephritis and Attenuates the Lupus-Like Disease in Lupus Murine Models by Inducing a More Tolerogenic Immune Phenotype.
35. Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients.
36. Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III Study.
37. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
38. Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles.
39. Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma.
40. SERPINB3 is associated with longer survival in transgenic mice.
41. IgM-Linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease.
42. APC I1307K mutations and forkhead box gene (FOXO1A): another piece of an interesting correlation.
43. Antiphospholipid antibody ELISAs: Survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-β2-Glycoprotein I activity
44. Simple and Safe Method to Prepare Patients With Prosthetic Heart Valves for Surgical Dental Procedures.
45. Engineered EVs for Oxidative Stress Protection.
46. SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.
47. HIF‐2α mediates hypoxia‐dependent upregulation of Serpin‐B3, a marker of early liver carcinogenesis (144.7).
48. Association of the G20210A mutation in the factor II gene with systemic embolism in nonvalvular atrial fibrillation
49. FRI-117-The gain of function mutation of SerpinB3 (SCCA-PD) is associated with the severity of portal hypertension and complications onset in patients with advanced liver disease.
50. SAT039 - SERPINB3 inhibition as a novel target therapy for non-alcoholic steatohepatitis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.